Class Central is learner-supported. When you buy through links on our site, we may earn an affiliate commission.

YouTube

Development of a T Cell Engineering Platform for Fully Individualized Neoantigen-Specific TCR Therapy

Labroots via YouTube

Overview

Save Big on Coursera Plus. 7,000+ courses at $160 off. Limited Time Only!
Explore a 34-minute webinar presented by Dr. Xiangjun Kong, Principal Scientist at Neogene Therapeutics, on the development of a T cell engineering platform for individualized neoantigen-specific TCR therapy. Gain insights into a promising new immunotherapy approach involving adoptive transfer of T cell receptor (TCR)-edited T cells targeting cancer neoantigens. Learn about the high-throughput, patient-specific platform developed to identify neoantigen-reactive TCRs. Discover Dr. Kong's extensive research background in functional screening, genome editing technologies, and novel targeted and immune therapy strategies for cancer. Understand the potential impact of this innovative approach on personalized cancer treatment.

Syllabus

Development of a T cell engineering platform for fully individualized neoantigen specific TCR...

Taught by

Labroots

Reviews

Start your review of Development of a T Cell Engineering Platform for Fully Individualized Neoantigen-Specific TCR Therapy

Never Stop Learning.

Get personalized course recommendations, track subjects and courses with reminders, and more.

Someone learning on their laptop while sitting on the floor.